Dublin, Ireland, 19th January, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback